Prochlorperazine Edisylate Injection, Solution
Product Images NDC 83634-778

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Prochlorperazine Edisylate (NDC 83634-778). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avenacy Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Pro2d 0000 01)

Structural Formula (Pro2d 0000 01)
Chemical structure of prochlorperazine edisylate showing molecular bonds and functional groups, including a piperazine ring, chlorine atom, and sulfonic acid groups.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL – Vial Label)

Package Label (PRINCIPAL DISPLAY PANEL – Vial Label)
Label for prochlorperazine edisylate injection, USP, 10 mg per 2 mL (5 mg per mL) solution for intramuscular or intravenous use. Multi-dose vial of 2 mL with directions to protect from light and a warning that it is not for subcutaneous use. Manufactured by Avenacy Inc. with NDC 83634-778.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.